Posts filtered by tags: Cancer[x]


Despite Buyout, Celgene Dealmaking Rolls On With Kyn, Obsidian Tie-Ups

[Updated 12:35pm ET with comments from Michael Gilman, Obsidian CEO, see below.] Bristol-Myers Squibb’s huge proposed buyout of Celgene earlier this month has left many in biotech circles concerned that the Summit, NJ, drugmaker’s days of creative, aggressive dealmaking with smaller companies might be over. So far, however, that isn’t the case.Two Boston-area biotechs, Kyn Therapeutics and Obsidian Therapeutics, announced deals this morning with Celgene (NASDAQ: CELG). Both partnerships bring C...
Tags: Deals, Boston, Cancer, Trends, Immunotherapy, Biotech, Life Sciences, Celgene, Bristol-myers Squibb, Obsidian, National blog main, New York blog main, New York top stories, Boston blog main, National top stories, Boston top stories

Living With Cancer: A Cancer Rap, With Thanks to Nina Simone

After too many cancer-related setbacks and deaths I started belting Nina Simone’s protest with new words, invigorated by her spirit of indignant fury.
Tags: Music, News, Cancer, Nina Simone, Simone, Nina, Race and Ethnicity, Poetry and Poets

The Notorious RBG is cancer free and will return to the Supreme Court

Frazzled American nerves should be calmed by Supreme Court spokeswoman Kathleen L. Arberg's statement that Justice Ruth Bader Ginsberg is cancer free. The beloved justice is recovering and will return to hear oral arguments next week. The Trump Administration was reportedly chomping at the bit to replace this well-loved member of the Supreme Court. NPR: Justice Ruth Bader Ginsburg has no remaining signs of cancer after her surgery last month, requires no additional treatment, but will miss o...
Tags: Post, News, Supreme Court, Cancer, Ruth Bader Ginsburg, Ruth Bader Ginsberg, RBG, Trump Administration, Kathleen L Arberg, Supreme Court NPR

Ruth Bader Ginsburg Is Cancer Free After Surgery, Supreme Court Says

The justice’s recovery from surgery “is on track,” said a court spokeswoman, and no further treatment is required.
Tags: News, Cancer, Ruth Bader Ginsburg, Ginsburg, Ruth Bader, Supreme Court (US, Washington (DC

Is granting children's wishes cost-effective? A new study looks at Make-A-Wish.

Make-A-Wish stories are heartwarming, but are they worth the cost?Effective donations to the right charities can save lives, even if they don't make for good reading.A recent study into the value of wishes on health care costs gives good news for everybody. Remember Batkid? That adorable little cancer patient who saved San Francis— I mean, Gotham, from the Riddler and Penguin? Who had a whole article about him in the San Francisco Chronicle written by Clark Kent? Who reminded us that the world i...
Tags: Children, Cancer, Gotham, Innovation, Columbia University, Health Care, Penguin, Vox, Philanthropy, Batkid, Peter, San Francisco Chronicle, Peter Singer, Against Malaria Foundation, Wish Foundation, Clark Kent

These new keto diet tortillas are made of 100% cheese

To help keto dieters stay the course, Lotito Foods has developed the Folios cheese wrap, a tortilla made entirely of cheese.These cheese wraps can be part of a healthy diet, but only if eaten in extreme moderation and alongside low-fat, low-salt foods. Research shows that replacing grains and fiber with fat and salts in the long term can be dangerous. None Now they've gone and done it. Keto diet enthusiasts have concocted all manner of unsettling dishes to kick the carbs: coffee with butter inst...
Tags: Health, Cancer, Happiness, Choice, Public Health, Medical Research, Innovation, Agriculture, Disease, Keto, European Society of Cardiology, Bonnie Taub Dix, Taub Dix, Jaha, Human body, Keto Diet

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

Diabetes drugs are Eli Lilly’s bread and butter, but the pharmaceutical giant hasn’t lost its appetite for cancer drugs. It grabbed hold of a few more this week by betting $8 billion on Loxo Oncology.Loxo (NASDAQ: LOXO) has made a name for itself by becoming one of just two companies ever to earn an FDA approval for a drug that targets a tumor’s DNA fingerprint, no matter where in the body that cancer is found. The drug, larotrectinib, targets rare tumor abnormalities known as NTRK fusions. The...
Tags: Deals, Startups, Ipo, Cancer, Trends, Medicare, SEC, Fda, National, GlaxoSmithKline, Allergan, Shire, Biotech, Medical Device, Postpartum Depression, Bernie Sanders

Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ

When Black Diamond Therapeutics emerged from stealth mode last month with $20 million in backing and a handful of preclinical cancer drugs, the company signaled that another financing was in the works for 2019. That day is here.Black Diamond announced late Wednesday that it has closed $85 million in Series B financing, which the company says it will use to advance its top drug candidates into human testing within the next two years.Black Diamond was incubated within the Switzerland drug discove...
Tags: Deals, Startups, Boston, Cancer, Trends, Venture Capital, Switzerland, Biotech, Drug, New Enterprise Associates, Life Sciences, Black Diamond, Clinical Trials, Allosteric, Versant Ventures, National blog main

How to Be Part of the Decline in Cancer Death Rates

Death rates from cancer are down by 27 percent over the last 25 years, according to a new report from the American Cancer Society. Smoking is a big part of that (lung cancer deaths are way down), and treatments have gotten better over the decades.Read more...
Tags: Health, Nutrition, Smoking, Diet, Cancer, Exercise, Lifehacks, Good News, American Cancer Society Smoking

Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks

AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.
Tags: News, Cancer, Astrazeneca, Conflicts Of Interest, Jose, AstraZeneca PLC, Baselga, José Baselga, Memorial Sloan-Kettering Cancer Center, Memorial Sloan Kettering, Drugs (Pharmaceuticals

Nonfiction: Could Immunotherapy Offer a Cure for Cancer?

In “The Breakthrough,” Charles Graeber recounts the long history of researchers’ attempts to mobilize the body’s immune system to fight disease.
Tags: News, Cancer, Immunotherapy, Allison, James P, Books and Literature, Charles Graeber, Breakthrough (Book

Ruth Bader Ginsburg misses supreme court arguments for first time in 25 years

Court spokeswoman says Ginsburg, 85, is working from home as she recuperates from cancer surgery last monthRuth Bader Ginsburg was on Monday missing supreme court arguments for the first time in more than 25 years, as she recuperates from cancer surgery last month, the court said.Ginsburg was not on the bench as the court met to hear arguments. It was not clear when she would return to the court, which will hear more cases on Tuesday and Wednesday and again next week. Continue reading...
Tags: Cancer, US news, US politics, Ruth Bader Ginsburg, US supreme court, Ginsburg, Bader Ginsburg, Law (US

Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition

[Updated 1/7/19, 11 a.m. ET. See below.] Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion—a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.Under the agreement announced Monday, Lilly (NYSE: LLY) will pay $235 cash per share of Loxo (NASDAQ: LOXO), which is a 68 percent premium to the Friday closing price of the Stamford, CT, cancer drug developer. Following the news of the deal, shares of Lox...
Tags: Deals, Drugs, Cancer, Trends, Indiana, Indianapolis, Mergers and Acquisitions, Fda, GlaxoSmithKline, Biotech, Life Sciences, Bayer, Clinical Trials, Celgene, American Society of Clinical Oncology, Stamford

Gofundme jumpstarts a golden era of snake oil as desperate people raise millions for quack homeopathy cancer "remedies"

In Patients' crowdfunding campaigns for alternative cancer treatments, published by researchers from Simon Fraser University in The Lancet Oncology ( ) we learn that thanks to Gofundme, 13,000 people have raised $1.4 million to help 200 desperate cancer patients pay for ineffective homeopathic "treatments." A third of these fundraisers were launched by people who explicitly rejected evidence-based medicine and were seeking money to commit an especially grisly form of suicide, while enrichin...
Tags: Health, Post, Business, News, Crowdfunding, Woo, Cancer, Fraud, Fuck Cancer, Homeopathy, Gofundme, Simon Fraser University, Snyder, Timothy Caulfield, Jeremy Snyder, Snake Oil

Genentech, Adaptive Bio Join Forces on Personalized Cancer Drugs R&D

Genentech is paying Adaptive Biotechnologies $300 million up front in a new partnership focused on developing cancer immunotherapies personalized to individual patients.Seattle-based Adaptive has technology that can analyze the immune system to find targets for cell therapies. Adaptive says that its screening technology enables it to discover T-cell receptors (TCRs) that can recognize and target neoantigens, which are proteins generated by tumor mutations.Under the agreement announced Friday, A...
Tags: Deals, Startups, Cancer, Trends, Biotech, Seattle, Life Sciences, Personalized Medicine, Clinical Trials, Genentech, Roche, Adaptive Biotechnologies, Fred Hutchinson Cancer Research Center, National blog main, Seattle blog main, Seattle top stories

Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer

A new class of ovarian and breast cancer drugs that thwart a DNA repair mechanism ushered in a novel approach to treating cancer. The first PARP inhibitor was approved in 2014. That drug, and others that followed, block a PARP enzyme that plays a key role in this repair process. But it turns out there’s more than one type of PARP—17, to be exact. Ribon Therapeutics aims to target other PARPs with small molecule drugs, and the Boston-area startup has raised $65 million in financing to bring its ...
Tags: Deals, Startups, Boston, Cancer, Funding, Trends, Venture Capital, Astrazeneca, Biotech, Series B, Life Sciences, Oncology, Celgene, Olaparib, Osage University Partners, National blog main

Ties: I Could Face My Own Mortality, but My Son’s Was Another Story

After my near-death experience, I lost my fear of death. I didn’t expect to feel so blindsided when my son got leukemia.
Tags: News, Parenting, Cancer, Leukemia, Death and dying, Philosophy, Families and Family Life

GoFundMe Is Still Enabling 'Garbage' Cancer Treatment Scams, Study Finds

Medical crowdfunding has become a billion-dollar industry practically overnight, led by sites like GoFundMe. But yet another new study shows a dark side of the trend: Millions of dollars funneled to ludicrous, unscientific treatments for life-threatening diseases like cancer. Tragically, the study also found that many…Read more...
Tags: Science, Crowdfunding, Cancer, Scams, Pseudoscience, Homeopathy

Tizona Lands $105M from AbbVie in Cancer Drug R&D Alliance

A cancer immunotherapy teed up for clinical trials by Tizona Therapeutics is now the centerpiece of a new partnership with AbbVie, which is paying the startup $105 million up front.In addition to the cash paid to South San Francisco, CA-based Tizona, AbbVie (NYSE: ABBV) said Thursday that it has made an equity investment in its partner. The amount of the investment wasn’t disclosed.Tizona develops drugs intended to inhibit the activity of enzymes on the surface of tumor cells that suppress the ...
Tags: Deals, Startups, Drugs, Cancer, San Francisco, Trends, Investing, Fda, Abbvie, Biotech, Life Sciences, Clinical Trials, Roche, South San Francisco CA, National blog main, San Francisco blog main

Couple forced to close raffle for their £500,000 North Yorkshire home

Thousands of £10 tickets sold before Gambling Commission told pair it was not legalA retired couple who offered the chance to win their £500,000 four-bedroom home and swimming pool with a £10 raffle ticket have had to close the competition with “sincere regret and upset”.Robert and Avril Smith announced last year that they were hoping to sell 60,000 of the £10 tickets, giving the public a chance to win their home in Grosmont, North Yorkshire. Continue reading...
Tags: Cancer, UK News, Charities, Yorkshire, Robert, Gambling Commission, Avril Smith, Grosmont North Yorkshire Continue

How Cancer Changes Hope

Facing death, I felt the connection between the past and the present more deeply than I ever thought I would.
Tags: News, Cancer, New Year, Duke Divinity School, Religion and Belief, Seneca (4 BC-AD 65

Hope Isn’t Just About the Future

Facing death, I felt the connection between the past and the present more deeply than I ever thought I would.
Tags: News, Cancer, New Year, Duke Divinity School, Religion and Belief, Seneca (4 BC-AD 65

August Alsina’s Sister Died on Christmas Night After Battle With Cancer

August Alsina is mourning the loss of his sister who died on Christmas night.The R&B singer took this his Instagram page on Wednesday (Dec. 26) to announce that his sister Chandra had passed away after a bout with cancer.The post included a tribute video dedicated to his late sister featuring his song “Other Side” along with a lengthy message about how he is “devastated” and “deeply shattered” over the passing of his “number one fan.”“Chandra… My Sister, My friend, life giver to my nieces, my ha...
Tags: Family, Celebs, Cancer, Pop Culture, Jazz, Mel, Trending, Melvin, Chandra, Alsina, August Alsina

Ruth Bader Ginsburg Is Discharged From Hospital After Surgery

Justice Ginsburg is recovering at home after having two malignant nodules removed from her lung on Friday, a Supreme Court spokeswoman said.
Tags: News, Supreme Court, Cancer, Ruth Bader Ginsburg, Ginsburg, Ruth Bader, Supreme Court (US, Surgery and Surgeons

Study: THC in cannabis linked to genetic mutations in sperm

Today I learned that using cannabis can lower a fella's sperm count: those looking to partake in parenthood should take note. But that's not the only thing that cannabis can do to your swimmers. According to scientists from Duke University, using marijuana can cause genetic changes to sperm cells--something that could have far-reaching consequences for any baby a dude might father. From The Verge: For a study published today in the journal Epigenetics, scientists at Duke University compared the...
Tags: Post, News, Marijuana, Cancer, Genetics, Duke University, Thc, Mutation, Ask your doctor if Cannabis is right for you, Today in disapointing science

San Francisco Biotech: The Next Generation—Photos and Takeaways

View the Slideshow Among the life science companies developing new approaches to disease today are those that will shape the healthcare of tomorrow.  Earlier this month, Xconomy offered a select audience a peek at some of them making advances in the Bay Area.Three companies aiming to transform healthcare took to the stage at UCSF Mission Bay on Dec. 6 for San Francisco Biotech: The Next Generation. First up was RDMD, a San Francisco startup that is bringing a . CEO and co-founder ... Read ...
Tags: Startups, Drugs, Ipo, Cancer, San Francisco, Trends, Tech, Investing, It, Software, Alzheimer's Disease, Fda, Biotech, Life Sciences, Clinical Trials, David Chang

Bacon-cancer link: head of UN agency at heart of furore defends its work

IARC’s outgoing director attacks vested interests of critics but admits it could have communicated betterThe head of the UN agency that provoked a massive outcry and some ridicule when it declared that bacon, red meat and glyphosate weedkiller caused cancer has defended its work, denying the announcements were mishandled and insisting on its independence.Its outgoing director, Christopher Wild, fiercely defended the decisions and transparency of the International Agency for Research on Cancer (I...
Tags: Health, Science, Cancer, Society, World news, Medical Research, Un, Cancer Research, IARC, International Agency for Research on Cancer IARC, Christopher Wild

Gates Foundation, Bristol-Myers Join $27M Funding for Vedanta Bio

Microbiome drug developer Vedanta Biosciences has raised $27 million in funding to press forward with clinical trials for four therapeutic candidates.Vedanta’s experimental treatments are compositions of live bacteria that the Cambridge, MA, company says trigger a targeted immune response. By shifting the ecosystem of gut bacteria, Vedanta says its therapies can potentially treat autoimmune and allergic diseases, as well as cancer.The company’s most advanced drug candidate, VE303, has started a...
Tags: Deals, Startups, Drugs, Boston, Cancer, Trends, Investing, Venture Capital, Cambridge, Biotech, Microbiome, Ubiome, Life Sciences, Clinical Trials, Nivolumab, Vedanta